ACADIA Pharmaceuticals
ACAD
#3822
Rank
โ‚ฌ2.14 B
Marketcap
12,88ย โ‚ฌ
Share price
1.88%
Change (1 day)
-17.66%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2023 (TTM): -0,86ย โ‚ฌ

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,81ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,18ย โ‚ฌ a decrease over its 2021 EPS that were of -0,92ย โ‚ฌ.

EPS history for ACADIA Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,86ย โ‚ฌ-27.25%
2022-1,18ย โ‚ฌ27.62%
2021-0,92ย โ‚ฌ-41.67%
2020-1,59ย โ‚ฌ12.5%
2019-1,41ย โ‚ฌ-17.95%
2018-1,72ย โ‚ฌ-17.02%
2017-2,07ย โ‚ฌ0.43%
2016-2,06ย โ‚ฌ43.56%
2015-1,44ย โ‚ฌ73.4%
2014-0,83ย โ‚ฌ113.64%
2013-0,39ย โ‚ฌ18.92%
2012-0,33ย โ‚ฌ-15.91%
2011-0,39ย โ‚ฌ-210%
20100,35ย โ‚ฌ-133.61%
2009-1,05ย โ‚ฌ-30.81%
2008-1,51ย โ‚ฌ7.5%
2007-1,41ย โ‚ฌ-0.62%
2006-1,42ย โ‚ฌ4.55%
2005-1,36ย โ‚ฌ-14.61%
2004-1,59ย โ‚ฌ-84.26%
2003-10,09ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
0,24ย โ‚ฌ-129.35%๐Ÿ‡บ๐Ÿ‡ธ USA
1,64ย โ‚ฌ-302.17%๐Ÿ‡บ๐Ÿ‡ธ USA
4,78ย โ‚ฌ-690.14%๐Ÿ‡บ๐Ÿ‡ธ USA
12,41ย โ‚ฌ-1,631.01%๐Ÿ‡บ๐Ÿ‡ธ USA
3,50ย โ‚ฌ-531.52%๐Ÿ‡บ๐Ÿ‡ธ USA